426 related articles for article (PubMed ID: 19003550)
1. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
Cubo E; Martínez Martin P; González M; Frades B;
Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
[TBL] [Abstract][Full Text] [Related]
2. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
Martinez-Martin P; Rodriguez-Blazquez C; Abe K; Bhattacharyya KB; Bloem BR; Carod-Artal FJ; Prakash R; Esselink RA; Falup-Pecurariu C; Gallardo M; Mir P; Naidu Y; Nicoletti A; Sethi K; Tsuboi Y; van Hilten JJ; Visser M; Zappia M; Chaudhuri KR
Neurology; 2009 Nov; 73(19):1584-91. PubMed ID: 19901251
[TBL] [Abstract][Full Text] [Related]
3. Burden, perceived health status, and mood among caregivers of Parkinson's disease patients.
Martinez-Martin P; Arroyo S; Rojo-Abuin JM; Rodriguez-Blazquez C; Frades B; de Pedro Cuesta J;
Mov Disord; 2008 Sep; 23(12):1673-80. PubMed ID: 18709684
[TBL] [Abstract][Full Text] [Related]
4. [Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review].
Martínez-Martín P; Carroza-García E; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
Rev Neurol; 2009 Jul 1-15; 49(1):1-7. PubMed ID: 19557692
[TBL] [Abstract][Full Text] [Related]
5. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease.
Martinez-Martin P; Visser M; Rodriguez-Blazquez C; Marinus J; Chaudhuri KR; van Hilten JJ; ;
Mov Disord; 2008 Sep; 23(12):1681-8. PubMed ID: 18709672
[TBL] [Abstract][Full Text] [Related]
6. Psychometric attributes of the SCOPA-COG Brazilian version.
Carod-Artal FJ; Martínez-Martin P; Kummer W; Ribeiro Lda S
Mov Disord; 2008 Jan; 23(1):81-7. PubMed ID: 17987646
[TBL] [Abstract][Full Text] [Related]
7. Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease.
Cubo E; Martín PM; Martin-Gonzalez JA; Rodríguez-Blázquez C; Kulisevsky J;
Mov Disord; 2010 Jan; 25(1):70-5. PubMed ID: 20014110
[TBL] [Abstract][Full Text] [Related]
8. [A pilot study on a specific measure for sleep disorders in Parkinson's disease: SCOPA-Sleep].
Martínez-Martín P; Cubo-Delgado E; Aguilar-Barberà M; Bergareche A; Escalante S; Rojo A; Campdelacreu J; Frades-Payo B; Arroyo S;
Rev Neurol; 2006 Nov 16-30; 43(10):577-83. PubMed ID: 17099848
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Impression of Severity Index for Parkinson's Disease: international validation study.
Martínez-Martín P; Rodríguez-Blázquez C; Forjaz MJ; de Pedro J;
Mov Disord; 2009 Jan; 24(2):211-7. PubMed ID: 18973256
[TBL] [Abstract][Full Text] [Related]
10. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
[TBL] [Abstract][Full Text] [Related]
11. Psychometric properties of the SCOPA-AUT Brazilian Portuguese version.
Carod-Artal FJ; Ribeiro Lda S; Kummer W; Martinez-Martin P
Mov Disord; 2010 Jan; 25(2):205-12. PubMed ID: 19938162
[TBL] [Abstract][Full Text] [Related]
12. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
[TBL] [Abstract][Full Text] [Related]
13. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
14. [Study of associated clinical variables and phenomenology of hallucinations in Parkinson's].
Cubo E; González M; Aguilar A; Quintana S
Neurologia; 2006; 21(1):12-8. PubMed ID: 16525921
[TBL] [Abstract][Full Text] [Related]
15. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
Winter Y; von Campenhausen S; Brozova H; Skoupa J; Reese JP; Bötzel K; Eggert K; Oertel WH; Dodel R; Ruzicka E
Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915
[TBL] [Abstract][Full Text] [Related]
16. Costs of drug treatment in Parkinson's disease.
Dodel RC; Eggert KM; Singer MS; Eichhorn TE; Pogarell O; Oertel WH
Mov Disord; 1998 Mar; 13(2):249-54. PubMed ID: 9539337
[TBL] [Abstract][Full Text] [Related]
17. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.
Chaudhuri KR; Martinez-Martin P; Schapira AH; Stocchi F; Sethi K; Odin P; Brown RG; Koller W; Barone P; MacPhee G; Kelly L; Rabey M; MacMahon D; Thomas S; Ondo W; Rye D; Forbes A; Tluk S; Dhawan V; Bowron A; Williams AJ; Olanow CW
Mov Disord; 2006 Jul; 21(7):916-23. PubMed ID: 16547944
[TBL] [Abstract][Full Text] [Related]
18. Burden of illness in Parkinson's disease.
Huse DM; Schulman K; Orsini L; Castelli-Haley J; Kennedy S; Lenhart G
Mov Disord; 2005 Nov; 20(11):1449-54. PubMed ID: 16007641
[TBL] [Abstract][Full Text] [Related]
19. The health burdens of Parkinson's disease.
Chrischilles EA; Rubenstein LM; Voelker MD; Wallace RB; Rodnitzky RL
Mov Disord; 1998 May; 13(3):406-13. PubMed ID: 9613729
[TBL] [Abstract][Full Text] [Related]
20. Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson's disease patients.
Klepac N; Hajnsek S; Trkulja V
Parkinsonism Relat Disord; 2010 Jan; 16(1):21-7. PubMed ID: 19640772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
